ISSN 1662-4009 (online)

ey0018.6-15 | Longterm Effects of Hormonal Treatments in Gender Dysphoria | ESPEYB18

6.15. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty

MA van der Loos , I Hellinga , MC Vlot , DT Klink , M den Heijer , CM Wiepjes

J Bone Miner Res. 2021 May;36(5):931–941. doi: 10.1002/jbmr.4262. PMID: 33507568.This restrospective study of the Cohort of Gender Dysphoria investigated bone geometry parameters of 106 adolescent trans-women and 216 adolescent trans-men during early and late start of gonadotropin-releasing hormone agonist (GnRHa) and gender affirming hormone therapy (GAHT). Transgender youth who started tr...

ey0021.6-14 | Bone Health after Puberty Suppression and Gender Affirming Hormone Treatment | ESPEYB21

6.14. Bone mineral density in transgender adolescents treated with puberty suppression and subsequent gender-affirming hormones

Loos MATC van der , MC Vlot , DT Klink , SE Hannema , M den Heijer , CM Wiepjes

Brief Summary: This prospective follow-up cohort study investigated bone mineral density in transgender individuals who had initiated GnRH analogue treatment before age 18 followed by sex hormone treatment for at least 9 years. At a median age 28.2 years, after using testosterone for a median 11.9 years (IQR 10.2-13.8), transmasculine individuals had mean z-scores close to 0 at the lumbar spine, total hip and femoral neck, similar to z-scores at the start of GnRH analogue trea...